Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643994 · ClinicalTrials.gov registry record · NA
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
A NA study, sponsored by Accuray Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 379
- Enrollment target
NCT00643994 is a NA study that has completed, run by Accuray Incorporated. The registered enrollment target is 379 participants.
The verdict
NCT00643994, a NA study, has completed, sponsored by Accuray Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 379 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.
Interventions
- RADIATION CyberKnife Stereotactic Radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2007-12 |
| Est. Completion | 2021-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00643994
The ClinicalTrials.gov registry entry for NCT00643994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Accuray Incorporated, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CyberKnife Stereotactic Radiosurgery is the first listed.
NCT00643994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00643994 about?
NCT00643994 is a clinical study titled "CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution". The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.
What is the current status of trial NCT00643994?
This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2007-12. Estimated completion is 2021-01-27.
What interventions are being tested in trial NCT00643994?
The interventions under investigation include: CyberKnife Stereotactic Radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00643994?
This trial is sponsored by Accuray Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.